Gamgee
Gamgee develops personalized mRNA vaccines for dogs with cancer, designed from the genetic profile of each dog’s tumor.
$4MSeed
ParticipantAF
Arash Ferdowsi
Activity from announced rounds
Activity in this selectionUnited States · Aug 31, 2026 · Aug 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- 0 All roles disclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $4M 1 disclosed · full round size, not this investor’s share